BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 16854842)

  • 1. Evaluation of multiprotein immunoaffinity subtraction for plasma proteomics and candidate biomarker discovery using mass spectrometry.
    Liu T; Qian WJ; Mottaz HM; Gritsenko MA; Norbeck AD; Moore RJ; Purvine SO; Camp DG; Smith RD
    Mol Cell Proteomics; 2006 Nov; 5(11):2167-74. PubMed ID: 16854842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limitation of immunoaffinity column for the removal of abundant proteins from plasma in quantitative plasma proteomics.
    Ichibangase T; Moriya K; Koike K; Imai K
    Biomed Chromatogr; 2009 May; 23(5):480-7. PubMed ID: 19039805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse-specific tandem IgY7-SuperMix immunoaffinity separations for improved LC-MS/MS coverage of the plasma proteome.
    Zhou JY; Petritis BO; Petritis K; Norbeck AD; Weitz KK; Moore RJ; Camp DG; Kulkarni RN; Smith RD; Qian WJ
    J Proteome Res; 2009 Nov; 8(11):5387-95. PubMed ID: 19722698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgY14 and SuperMix immunoaffinity separations coupled with liquid chromatography-mass spectrometry for human plasma proteomics biomarker discovery.
    Shi T; Zhou JY; Gritsenko MA; Hossain M; Camp DG; Smith RD; Qian WJ
    Methods; 2012 Feb; 56(2):246-53. PubMed ID: 21925605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-component immunoaffinity subtraction chromatography: an innovative step towards a comprehensive survey of the human plasma proteome.
    Pieper R; Su Q; Gatlin CL; Huang ST; Anderson NL; Steiner S
    Proteomics; 2003 Apr; 3(4):422-32. PubMed ID: 12687610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rat plasma proteomics: effects of abundant protein depletion on proteomic analysis.
    Linke T; Doraiswamy S; Harrison EH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 849(1-2):273-81. PubMed ID: 17188586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depletion of abundant plasma proteins and limitations of plasma proteomics.
    Tu C; Rudnick PA; Martinez MY; Cheek KL; Stein SE; Slebos RJ; Liebler DC
    J Proteome Res; 2010 Oct; 9(10):4982-91. PubMed ID: 20677825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced detection of low abundance human plasma proteins using a tandem IgY12-SuperMix immunoaffinity separation strategy.
    Qian WJ; Kaleta DT; Petritis BO; Jiang H; Liu T; Zhang X; Mottaz HM; Varnum SM; Camp DG; Huang L; Fang X; Zhang WW; Smith RD
    Mol Cell Proteomics; 2008 Oct; 7(10):1963-73. PubMed ID: 18632595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affinity Capture Enrichment versus Affinity Depletion: A Comparison of Strategies for Increasing Coverage of Low-Abundant Human Plasma Proteins.
    Palstrøm NB; Rasmussen LM; Beck HC
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different immunoaffinity fractionation strategies to characterize the human plasma proteome.
    Gong Y; Li X; Yang B; Ying W; Li D; Zhang Y; Dai S; Cai Y; Wang J; He F; Qian X
    J Proteome Res; 2006 Jun; 5(6):1379-87. PubMed ID: 16739989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microscale depletion of high abundance proteins in human biofluids using IgY14 immunoaffinity resin: analysis of human plasma and cerebrospinal fluid.
    Hyung SW; Piehowski PD; Moore RJ; Orton DJ; Schepmoes AA; Clauss TR; Chu RK; Fillmore TL; Brewer H; Liu T; Zhao R; Smith RD
    Anal Bioanal Chem; 2014 Nov; 406(28):7117-25. PubMed ID: 25192788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance evaluation of affinity ligands for depletion of abundant plasma proteins.
    Kullolli M; Warren J; Arampatzidou M; Pitteri SJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Nov; 939():10-6. PubMed ID: 24090752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and Immunoaffinity Depletion of Fresh Frozen Tissue Homogenates for Mass Spectrometry-Based Proteomics in the Context of Drug Target/Biomarker Discovery.
    Prieto DA; Chan KC; Johann DJ; Ye X; Whitely G; Blonder J
    Methods Mol Biol; 2017; 1647():71-90. PubMed ID: 28808996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
    Smith JG; Gerszten RE
    Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced Detection of Low-Abundance Human Plasma Proteins by Integrating Polyethylene Glycol Fractionation and Immunoaffinity Depletion.
    Liu Z; Fan S; Liu H; Yu J; Qiao R; Zhou M; Yang Y; Zhou J; Xie P
    PLoS One; 2016; 11(11):e0166306. PubMed ID: 27832179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-Depth, Reproducible Analysis of Human Plasma Using IgY 14 and SuperMix Immunodepletion.
    Beer LA; Ky B; Barnhart KT; Speicher DW
    Methods Mol Biol; 2017; 1619():81-101. PubMed ID: 28674879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated proteomic sample preparation with combination of on-line high-abundance protein depletion, denaturation, reduction, desalting and digestion to achieve high throughput plasma proteome quantification.
    Li Y; Yuan H; Dai Z; Zhang W; Zhang X; Zhao B; Liang Z; Zhang L; Zhang Y
    Anal Chim Acta; 2021 Apr; 1154():338343. PubMed ID: 33736814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of human serum by liquid chromatography-mass spectrometry: improved sample preparation and data analysis.
    Govorukhina NI; Reijmers TH; Nyangoma SO; van der Zee AG; Jansen RC; Bischoff R
    J Chromatogr A; 2006 Jul; 1120(1-2):142-50. PubMed ID: 16574134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contributions of immunoaffinity chromatography to deep proteome profiling of human biofluids.
    Wu C; Duan J; Liu T; Smith RD; Qian WJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 May; 1021():57-68. PubMed ID: 26868616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed-mode ion exchange-based integrated proteomics technology for fast and deep plasma proteome profiling.
    Xue L; Lin L; Zhou W; Chen W; Tang J; Sun X; Huang P; Tian R
    J Chromatogr A; 2018 Aug; 1564():76-84. PubMed ID: 29935814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.